E
Tivic Health Systems, Inc. TIVC
$0.93 -$0.06-5.97% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Corporate Info
Phone Number
888 276 6888
Address
47685 Lakeview Blvd.
Fremont, CA 94538
Country
United States
Year Founded
2016
Details
Sector
Health Care
Industry
Health Care Equipment and Services
Employees
7
Business Description
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in San Antonio, Texas.